SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Merck Stops Blood Cancer Drug Trials After Risk Review

Merck stopped trials of a blood cancer drug after reviewing the risks.

MRK

Related stories